Cardiologs
Past, present, future
Their story
Since our foundation in 2014 in Paris, we have been focused on creating solutions that leverage the power of machine learning to help clinicians better manage patients suffering from cardiac arrhythmia disorders.
Very soon afterwards, we partnered with leading cardiology experts to develop and validate our cutting-edge solution.
Our Cardiologs Holter Platform is the worlds’ first medical device powered by deep learning technology to have the CE mark, and amongst the first to receive FDA clearance.
9
publications & abstracts
4
patents granted
20M+
ECGS processed
3000 years
of ECG signal
Over 1.8 million
patients diagnosed per year
2021
acquisition by Philips
Values
We value a positive mindset, collaboration, a sense of ownership, transparency, the ability to embrace ambiguity, a talk-less-do-more attitude, and a sense of humor to enjoy ourselves along the way. If you identify with our values and want to contribute to our company, we’d love to have you in!
Presentation
Cardiovascular disease is the first cause of premature death in the world. Arrhythmia is a set of heart conditions affecting tens of millions of people worldwide in which the heart beats with an abnormal rhythm, leading to symptoms such as syncope, palpitations, and stroke. It is crucial to diagnose an arrhythmia and start treatment before tragic consequences happen.
The most common exam to diagnose an arrhythmia is an ambulatory electrocardiogram (ECG), which records the electrical activity of the heart between 1 and 30 days, and even up to a few years in the case of implantable devices. The vast amounts of data generated by such tests still require experts to go through a time-consuming and labor-intensive process, resulting in elevated costs, treatment delays, and variable quality.
Cardiologs is on a mission to democratize access to expert cardiac care through medical-grade artificial intelligence and cloud technology.
Founded in 2014, Cardiologs provides a cloud-based solution powered by a medical-grade AI.
Cardiologs is the world’s first medical device powered by deep learning, to have received regulatory clearance (CE Mark in August 2016). It is also among the first to have received FDA clearance (June 2017). Cardiologs is commercialized in the US and France and plans to accelerate growth in the rest of Europe in 2021.
Cardiologs is a tight-knit team of more than 70 people, based between Boston, USA, and Paris, France.
In November 2021, we announced that we were being acquired by Philips to expand our cardiac portfolio.
In 2023, our Gender Equality Index score is 98/100.
What they are looking for
Cardiologs values passionate and enthusiastic individuals, who are excited by the idea of advancing medical technology. Everybody at Cardiologs is well-educated in their fields, has a great attitude and enjoys being a team-player!
Good to know
Cardiologs cares about its employees and believes every employee contributes to the success of the company. Their recruitment and leaderships teams nurture a culture that encourages independence, ingenuity, and growth. Cardiologs encourages continuous learning, supported by on-site Cardiology Training (delivered by Physicians), and established R&D and Software Teams.
At Cardiologs, there is a balance of work and fun. Every occasion is celebrated, be it in their beautiful offices or outside exploring new venues. Every year Cardiologs has an annual team off-site, in great locations such as Lisbon (Portugal), Valencia (Spain), Palma de Majorque (Spain)... Every week there are lots of exciting things to do, from Monday night yoga to team Karaoke! There’s always something fun going on!